PMA supplement
P920014 S019: HEARTMATE XVE LVAS
FDA PMA supplement · Normal 180 Day Track No User Fee · Thoratec Corp
Key facts
| Original PMA | P920014 |
|---|---|
| Supplement number | S019 |
| Supplement type | Normal 180 Day Track No User Fee |
| Reason for the supplement | Postapproval Study Protocol |
| Trade name | HEARTMATE XVE LVAS |
| Generic name | Ventricular (assist) bypass |
| Applicant | Thoratec Corp |
| Product code | DSQ |
| Received date | Feb 7, 2003 |
| Decision date | Jun 29, 2004 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: